New data from a post-hoc analysis of the phase 3a SCALE™ clinical development programme were presented at the 51st European Association for the Study of Diabetes (EASD) Annual Meeting.
from Obesity / Weight Loss / Fitness News From Medical News Today http://ift.tt/1iPekZP
mercredi 16 septembre 2015
weight loss fitnessNew data on Saxenda show early response predicts improvements in weight loss and cardiometabolic risk factors
Inscription à :
Publier les commentaires (Atom)
0 commentaires:
Enregistrer un commentaire